首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with a Modified NCCLS M38-A Method To Determine the Activity of Voriconazole against Clinical Isolates of Aspergillus spp.
【2h】

Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with a Modified NCCLS M38-A Method To Determine the Activity of Voriconazole against Clinical Isolates of Aspergillus spp.

机译:用改良的NCCLS M38-A方法比较Sensititre YeastOne比色抗真菌药盒测定伏立康唑对曲霉属临床分离物的活性的比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The susceptibilities of 63 isolates of Aspergillus spp. to voriconazole were evaluated by a modified NCCLS M38-A method and the Sensititre YeastOne method. The overall agreement was 82.5%, ranging from 100% for Aspergillus niger and Aspergillus terreus to 62.5% for Aspergillus flavus. Discrepancies between the methods were due to higher Sensititre MICs. The Sensititre YeastOne method could have potential value for susceptibility testing of Aspergillus spp. to voriconazole.
机译:63株曲霉菌的敏感性。用改良的NCCLS M38-A方法和Sensititre YeastOne方法评估伏立康唑的抗肿瘤药性。总体一致性为82.5%,范围从黑曲霉和陆地曲霉的100%到黄曲霉的62.5%。两种方法之间的差异是由于较高的MIC造成的。 Sensititre YeastOne方法可能对曲霉属菌种的药敏试验具有潜在价值。伏立康唑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号